7
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Delayed thrombocytopenia following abciximab therapy

, , &
Pages 151-155 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ernest L Mazzaferri Jr & John J Young. (2008) Abciximab: a review and update for clinicians. Expert Review of Cardiovascular Therapy 6:5, pages 609-618.
Read now

Articles from other publishers (9)

Louis Vincent, Delphine Bourneau-Martin, Anaïs Maurier, Marina Babin, Stéphane Delepine, Dominique Helley, Aurélie Grandvuillemin, Laurence Lagarce, Agnès Lillo-Le Louët & Marie Briet. (2021) Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review. Therapies 76:6, pages 687-693.
Crossref
CHETAN SHENOY & KISHORE J. HARJAI. (2011) Thrombocytopenia following Percutaneous Coronary Intervention. Journal of Interventional Cardiology 24:1, pages 15-26.
Crossref
William H MatthaiJrJr. (2010) Evaluation of thrombocytopenia in the acute coronary syndrome. Current Opinion in Hematology, pages 1.
Crossref
Eugenia Nikolsky & Pravin Kahale. 2009. Pharmacology in the Catheterization Laboratory. Pharmacology in the Catheterization Laboratory 270 279 .
Carlo Patrono, Colin Baigent, Jack Hirsh & Gerald Roth. (2008) Antiplatelet Drugs. Chest 133:6, pages 199S-233S.
Crossref
Edo Kaluski, Bunyad Haider, Olga Milo-Cotter & Marc Klapholz. (2007) Glycoprotein IIb/IIIa inhibitors: questioning indications and treatment algorithms. Cardiovascular Revascularization Medicine 8:4, pages 281-288.
Crossref
William H MatthaiJrJr. (2005) Thrombocytopenia in Cardiovascular Patients. Chest 127:2, pages 46S-52S.
Crossref
Carlo Patrono, Barry Coller, Garret A. FitzGerald, Jack Hirsh & Gerald Roth. (2004) Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects. Chest 126:3, pages 234S-264S.
Crossref
B.R. Curtis, A. Divgi, M. Garritty & R.H. Aster. (2004) Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. Journal of Thrombosis and Haemostasis 2:6, pages 985-992.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.